'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Medicare coverage is changing next month House passes the NDAA, $900 billion defense policy bill ...
STATEWIDE — GOV. KATHY HOCHUL has launched POWER UP, a $300 million initiative to make New York’s industrial sites both shovel-ready and power-ready for next-generation industries, including ...
On a small white table outside a Santa Ana furniture store, next to a stack of vanilla-flavored chonca pan dulces, religious candles surround three framed photographs of a smiling young Latino man.
Brian Walshe’s wife Ana, fell victim to “sudden unexplained death,” before he panicked and got rid of her body — because he thought everyone would blame him, his lawyer told jurors. The irony, of ...
In-N-Out is set to open restaurants in Tennessee ahead of the opening of its headquarters in the state, USA TODAY confirmed. In-N-Out said in a statement that it will open locations in Middle ...
In-N-Out Burger to open at least some restaurants by the end of 2025. In-N-Out Burger plans to start serving customers in Middle Tennessee by the end of 2025, though the company wasn't specific about ...
LONGMONT, Colo. — In-N-Out Burger is celebrating the grand opening of a new Colorado restaurant on Thursday. The California-based fast food chain will open a new restaurant location in Longmont at ...
A jury in a suburban town south of Boston is set to hear the murder case against Brian Walshe in the death of his wife, Ana Walshe, nearly three years after her disappearance garnered national ...
A black fan exposes a Alabama Crimson Tide fan for calling him racial slurs. No. 10-ranked Alabama Crimson Tide took down the Eastern Illinois University Panthers 56-0 on Senior Day. The game was ...
Next year, Michael and Susan Dell plan to move $250 into the new Trump accounts of millions of children under 10. You’ll need to live in the right ZIP code. By Ron Lieber and Nicholas Kulish On ...
Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...